Drawing for ENZYOMICS

USPTO serial 76239280

ENZYOMICS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ADKINS, CHRISTOPHER
Law office
TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ENZYOMICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

NORM D. ST. LANDAU

DRINKER BIDDLE & REATH LLPNORM D ST LANDAU1500 K ST NW STE 1100WASHINGTON, DC 20005-1208

Goods and services

ClassDescriptionStatusFirst use
042providing information in the field of scientific and medical research; laboratory research, scientific research, product research and development, pharmaceutical drug development, design and testing for new product development, development of new technology for others and product development consultation in the field of medical and scientific drug and enzyme usage, namely, rapid enzyme targets identification and validation with rational drug design of enzyme inhibitors, rational drug design of small molecule inhibitors and mRNA inhibitors or antisense oligonucleotide which is used to make compounds and drugs, which inhibit enzyme targets in-vitro and in animals or humans, functional genomics and proteomics, which provides information regarding a gene, enzyme or protein target combined with a multi-disciplinary process which relies on a combination of scientific competencies, including mechanistic enzymology and structure-based design, biophysics, x-ray crystallography, computational chemistry, computer-aided drug design, medicinal chemistry, combinatorial chemistry, molecular pharmacology, recombinant protein production, target assay development and functional assay developmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 25, 2005MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 23, 2005ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 13, 2004CNSIINQUIRY AS TO SUSPENSION MAILED—
Dec 13, 2004CNSISUSPENSION INQUIRY WRITTEN—
Nov 29, 2004RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 28, 2004CNSLLETTER OF SUSPENSION MAILED—
Mar 29, 2004PETGPETITION TO REVIVE-GRANTED—
Jan 14, 2004FAXXFAX RECEIVED—
Dec 10, 2003ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 10, 2003PETRPETITION TO REVIVE-RECEIVED—
Nov 10, 2003MAILPAPER RECEIVED—
May 7, 2003CNSIINQUIRY AS TO SUSPENSION MAILED—
Apr 25, 2003CFITCASE FILE IN TICRS—
Apr 11, 2002CNSLLETTER OF SUSPENSION MAILED—
Apr 1, 2002CNEAEXAMINERS AMENDMENT MAILED—
Oct 5, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 24, 2001DOCKASSIGNED TO EXAMINER—
Sep 24, 2001DOCKASSIGNED TO EXAMINER—
Jun 1, 2001AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—

Frequently asked questions

Related guidance